NCT01958437

Brief Summary

Remembering how to travel from one location to another is critical in everyday life, yet this vital ability declines with normal aging and can be further affected by conditions that disproportionately affect the elderly, such as vision loss or progressive dementia. Human and animal research has shown that two distinct memory systems interact during navigation. The first, referred to as allocentric navigation, is very flexible and uses spatial knowledge of key features or landmarks to develop and use a mental map of the environment. This approach involves brain regions that are critical for new learning and memory but that decline with age. The second, referred to as egocentric navigation, is inflexible and relies on "habit" memories that link specific features with specific directions. This approach relies on brain regions that are critical for "automatic" responses and that are relatively unaffected by age. The main problem is that allocentric navigation declines with age and is accompanied increased dependence on egocentric navigation. This change increases the risk of becoming disoriented or "lost" when traveling in unfamiliar areas or even when traveling new routes in familiar areas. Therefore, the main goal of this project is to examine whether non-invasive brain stimulation, specifically transcranial direct current stimulation, can improve allocentric navigation in healthy older adults and patients with mild cognitive impairment. Participants will complete two functional magnetic resonance imaging sessions while learning new environments. Before one of these sessions, participants will receive active brain stimulation over the parietal cortex. Before the other session, participants will receive sham brain stimulation over the parietal cortex. The effects of this stimulation will be evaluated using both an allocentric and an egocentric memory test. Physiologic effects will be evaluated using both task-based and resting-state MRI.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 23, 2013

Completed
8 days until next milestone

Study Start

First participant enrolled

October 1, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 9, 2013

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 23, 2017

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 24, 2017

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

August 31, 2018

Completed
Last Updated

August 31, 2018

Status Verified

August 1, 2018

Enrollment Period

3.5 years

First QC Date

September 23, 2013

Results QC Date

April 16, 2018

Last Update Submit

August 28, 2018

Conditions

Keywords

AgingAlzheimer's Disease/DementiaCognitive DisordersImagingMagnetic Resonance Imaging (MRI)NeurologyPhysical Medicine & Rehabilitationtranscranial direct current stimulation

Outcome Measures

Primary Outcomes (4)

  • Accuracy in Centimeters From Target Location for Allocentric

    1 active tDCS; 1 sham tDCS for each measure. Participants touched a screen (using a ELO 19" touchscreen monitor) to document the location of the landmark. The distance between the actual vs. selected location served as the dependent measure.

    Outcome assessed after each of 2 sessions (estimated within 1 week of each other)

  • Hippocampal BOLD Signal During Task-based fMRI

    BOLD signal change comparing active to sham tDCS during Allocentric navigation (i.e., active HD-tDCS \> sham HD-tDCS). Activation maps thresholded at p\<.01 with minimum cluster size of 5 voxels.

    change between active and sham tDCS sessions (<1month)

  • Dorsal Attention Network Connectivity During Resting-state fMRI

    Change in resting state functional connectivity strength between active and sham tDCS sessions. Strength is measured by Pearson r correlations between nodes, which are z-transformed, and summated.

    change between active and sham tDCS sessions (<1month)

  • Egocentric

    Number of turns correctly recalled for each egocentric environment

    Outcome assessed after each of the 2 sessions

Study Arms (4)

Cognitively intact older adults - ACTIVE tDCS

EXPERIMENTAL

Group receives active brain stimulation

Device: Transcranial direct current stimulation (tDCS)

MCI ACTIVE tDCS

ACTIVE COMPARATOR

Group receives active brain stimulation

Device: Transcranial direct current stimulation (tDCS)

Cognitively intact older adults - SHAM tDCS

SHAM COMPARATOR

Group receives sham brain stimulation

Device: Transcranial direct current stimulation (tDCS)

MCI SHAM tDCS

SHAM COMPARATOR

Group receives sham brain stimulation

Device: Transcranial direct current stimulation (tDCS)

Interventions

Active and/or sham; All participants receive both stimulation condition. Groups will be counterbalanced (half receiving active tDCS in the first session and sham in the second session; the other half receiving the opposite).

Cognitively intact older adults - ACTIVE tDCSCognitively intact older adults - SHAM tDCSMCI ACTIVE tDCSMCI SHAM tDCS

Eligibility Criteria

Age50 Years - 88 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All medications stable for approximately 1-2 months;
  • No history of severe mental illness;
  • No current untreated alcohol or substance abuse/dependence;
  • English as native and preferred language;
  • MRI-compatible if taking part in fMRI studies
  • Able to give informed consent.
  • Diagnosis of amnestic MCI based on criteria set forth by Petersen (2004). Additionally, other potential causes of cognitive deficit ruled out by the referring physician;
  • Healthy older adults
  • intact cognitive functioning as measured by neuropsychological testing

You may not qualify if:

  • History of neurological disease or injury
  • History of severe mental illness
  • Current untreated alcohol or substance abuse
  • Other conditions may exclude; please discuss with contact

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Atlanta VA Medical and Rehab Center, Decatur, GA

Decatur, Georgia, 30033, United States

Location

VA Ann Arbor Healthcare System, Ann Arbor, MI

Ann Arbor, Michigan, 48105, United States

Location

Related Publications (2)

  • England HB, Fyock C, Meredith Gillis M, Hampstead BM. Transcranial direct current stimulation modulates spatial memory in cognitively intact adults. Behav Brain Res. 2015 Apr 15;283:191-5. doi: 10.1016/j.bbr.2015.01.044. Epub 2015 Jan 31.

  • Lengu K, Ryan S, Peltier SJ, Tyszkowski T, Kairys A, Giordani B, Hampstead BM. Effects of High Definition-Transcranial Direct Current Stimulation on Local GABA and Glutamate Levels Among Older Adults with and without Mild Cognitive Impairment: An Exploratory Study. J Alzheimers Dis. 2021;84(3):1091-1102. doi: 10.3233/JAD-201091.

MeSH Terms

Conditions

Cognitive DysfunctionAlzheimer DiseaseDementia

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Results Point of Contact

Title
Dr. Benjamin Hampstead
Organization
VA Ann Arbor Healthcare System; University of Michigan

Study Officials

  • Benjamin M Hampstead, PhD

    VA Ann Arbor Healthcare System, Ann Arbor, MI

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Double blinded
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Transcranial Direct Current Stimulation
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 23, 2013

First Posted

October 9, 2013

Study Start

October 1, 2013

Primary Completion

March 23, 2017

Study Completion

March 24, 2017

Last Updated

August 31, 2018

Results First Posted

August 31, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

Locations